ResMed Inc boss Mick Farrell says the medical device maker is seeing more patients returning to get diagnosed for obstructive sleep apnoea across the world as nations control COVID-19.
The dual-listed giant revealed that first quarter revenue jumped by 9 per cent to $US751.9 million ($1.05 billion), on a constant currency basis. In August it said revenue had grown by low single digits in the the first month of the new fiscal year.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
